Peripheral arterial disease — the atherosclerotic occlusion of lower extremity arteries affecting approximately eight to twelve million Americans causing claudication, rest pain, and limb-threatening critical limb ischemia — creates the clinical burden that drives the peripheral angioplasty and endovascular intervention market, with the Peripheral Angioplasty Market reflecting...